Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ELP3/KAT9 antibody

This Rabbit Monoclonal antibody specifically detects ELP3/KAT9 in WB and IHC. It exhibits reactivity toward Human.
Catalog No. ABIN1680361

Quick Overview for ELP3/KAT9 antibody (ABIN1680361)

Target

See all ELP3/KAT9 (ELP3) Antibodies
ELP3/KAT9 (ELP3) (Elongator complex protein 3 (ELP3))

Reactivity

  • 40
  • 15
  • 5
  • 1
Human

Host

  • 37
  • 4
Rabbit

Clonality

  • 38
  • 3
Monoclonal

Conjugate

  • 30
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ELP3/KAT9 antibody is un-conjugated

Application

  • 27
  • 10
  • 9
  • 8
  • 6
  • 4
  • 3
  • 2
  • 2
Western Blotting (WB), Immunohistochemistry (IHC)
  • Cross-Reactivity

    Human, Mouse, Rat

    Characteristics

    Monoclonal Antibodies

    Purification

    Affinity purification

    Immunogen

    A synthesized peptide derived from human KAT9/Elp3

    Isotype

    IgG
  • Application Notes

    WB,1:500 - 1:2000,IHC,1:50 - 1:200

    Restrictions

    For Research Use only
  • Buffer

    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C. Avoid freeze / thaw cycles.
  • Target

    ELP3/KAT9 (ELP3) (Elongator complex protein 3 (ELP3))

    Alternative Name

    ELP3

    Background

    ELP3 is the catalytic subunit of the histone acetyltransferase elongator complex, which contributes to transcript elongation and also regulates the maturation of projection neurons (Creppe et al., 2009 [PubMed 19185337]).[supplied by OMIM, Apr 2009],KAT9,Epigenetic writers and erasers of core Histones,Epigenetic writers and erasers of core Histones_Acetylation,Epigenetics & Nuclear Signaling,ELP3

    Molecular Weight

    62 kDa

    Gene ID

    55140

    UniProt

    Q9H9T3
You are here:
Chat with us!